Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 87.2%, against 71.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 87.2% | +15.3 |
| FY2024 | Dec 31, 2024 | 71.9% | +21.8 |
| FY2023 | Dec 31, 2023 | 50.1% | −3.3 |
| FY2022 | Dec 31, 2022 | 53.4% | – |
See a number that looks wrong?